Oxford Asset Management’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q1
Sell
-41,289
Closed -$530K 1749
2018
Q4
$530K Buy
+41,289
New +$530K 0.01% 1171
2017
Q4
Sell
-78,126
Closed -$318K 1689
2017
Q3
$318K Sell
78,126
-15,457
-17% -$62.9K 0.01% 1328
2017
Q2
$303K Buy
+93,583
New +$303K 0.01% 1255
2016
Q1
Sell
-51,745
Closed -$173K 832
2015
Q4
$173K Buy
+51,745
New +$173K ﹤0.01% 810